Status:
COMPLETED
Zinc and Selenium Bioactivity
Lead Sponsor:
University of Lahore
Conditions:
Immunomodulatory Drugs
Tuberculosis
Eligibility:
All Genders
30-55 years
Phase:
NA
Brief Summary
The primary hypothesis of the study was that zinc and selenium supplementation through fortified cookies would enhance the immune response and improve clinical outcomes in tuberculosis patients. For t...
Detailed Description
2\. Materials and methods 2.1. Procurement of raw materials Shiitake was procured from the departmental store of Lahore and placed in a sealed bag (Zip bag). All the research work was performed at the...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients aged 30-55 years.
- Confirmed diagnosis of pulmonary tuberculosis (Pul-TB) with positive acid-fast bacilli (AFB) in sputum samples.
- Exclusion Criteria
- Patients diagnosed with extra-pulmonary TB.
- Patients who had been on anti-TB therapy for more than 2 months prior to enrollment.
Exclusion
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07180329
Start Date
February 1 2023
End Date
July 25 2023
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sana Noreen
Lahore, Pakistan, 54000